REGISTERED NUMBER: 10644937 (England and Wales)

Unaudited Financial Statements for the Year Ended 30 November 2025

for

Queens Road Pharma Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

S Patel

Miss R K Raghwani

REGISTERED OFFICE:

39 Bromley Road

Catford

London

SE6 2TS

REGISTERED NUMBER:

10644937 (England and Wales)

ACCOUNTANTS:

Kallis LLP

Chartered Certified Accountant

22 Westward Way

Harrow

Middlesex

HA3 0SE

FIXED ASSETS

Intangible assets

4

83,334

122,134

Tangible assets

5

1,037,819

1,059,850

1,121,153

1,181,984

CURRENT ASSETS

Stocks

6

74,653

85,646

Debtors

7

97,230

78,264

Cash at bank and in hand

191,452

43,565

363,335

207,475

CREDITORS

Amounts falling due within one year

8

261,340

449,328

NET CURRENT ASSETS/(LIABILITIES)

101,995

(241,853

)

TOTAL ASSETS LESS CURRENT LIABILITIES

1,223,148

940,131

CAPITAL AND RESERVES

Called up share capital

10

10

Retained earnings

1,223,138

940,121

SHAREHOLDERS' FUNDS

1,223,148

940,131

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 August 2026 and were signed on its behalf by:

S Patel - Director

1.	STATUTORY INFORMATION

Queens Road Pharma Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Purchased goodwill is initially recognised at cost. After recognition purchased goodwill is amortised over its expected useful life and measured at cost less accumulated amortisation.

Goodwill is considered to have a finite useful life. If a reliable estimate of the useful cannot be made, the useful life shall not exceeds 10 years.

Tangible fixed assets

Tangible fixed assets are stated at cost less accumulated depreciation and accumulated impairment losses.Cost includes costs directly attributable to making the asset capable of operating as intended.Depreciation is provided on all tangible fixed assets,except land, at rates calculated to write off the cost, less estimated residual value, of each asset on a systematic basis over its expected useful lie as follows:

Freehold Property :2% on costs

Fixture, Fittings and equipments: 25% on reducing balance

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 9 (2024 - 11 ) .

4.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 December 2024

and 30 November 2025

388,000

AMORTISATION

At 1 December 2024

265,866

Charge for year

38,800

At 30 November 2025

304,666

NET BOOK VALUE

At 30 November 2025

83,334

At 30 November 2024

122,134

5.	TANGIBLE FIXED ASSETS

Fixtures

Freehold

and

Computer

property

fittings

equipment

Totals

£

£

£

£

COST

At 1 December 2024

1,048,696

56,931

4,035

1,109,662

Additions

-

9,300

-

9,300

At 30 November 2025

1,048,696

66,231

4,035

1,118,962

DEPRECIATION

At 1 December 2024

20,974

26,462

2,376

49,812

Charge for year

20,974

9,942

415

31,331

At 30 November 2025

41,948

36,404

2,791

81,143

NET BOOK VALUE

At 30 November 2025

1,006,748

29,827

1,244

1,037,819

At 30 November 2024

1,027,722

30,469

1,659

1,059,850

6.

STOCKS

30.11.25

30.11.24

£

£

Stocks

74,653

85,646

7.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.11.25

30.11.24

£

£

Trade debtors

55,784

60,681

VAT

34,627

13,931

Prepayments

6,819

3,652

97,230

78,264

8.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.11.25

30.11.24

£

£

Trade creditors

123,989

133,364

Tax

114,616

97,741

Other creditors

-

195,000

Directors loan accounts

10,025

8,929

Accrued expenses

12,710

14,294

261,340

449,328